Photo by Thomson200, CC0, via Wikimedia CommonsSixty Days
Chris Sale has thrown 117 innings this season and zero since June 18. The distance between those two numbers is where Anthopoulos has to make his decision.
The 60-day injured list is not a medical diagnosis. It is a calendar constraint.
Chris Sale fractured his left rib cage on June 18 when a line drive found the space between his glove and his torso. He has not thrown a pitch in a major league game since. The 60-day IL was retroactive to June 19, which makes his earliest possible activation date August 19 — sixteen days after Monday's trade deadline passes at 6:00 PM.
Sixteen days. That is the gap between Anthopoulos's decision and its validation. He will make the call on Monday without knowing whether Sale's body will cooperate. By the time the first rehab fastball leaves Sale's hand in Gwinnett — targeted for approximately August 12 — the deadline will have been closed for nine days. Every arm that was available will have moved or stayed. The decision will be final. The information it required will not yet exist.
This is the problem with trusting biology: biology does not observe deadlines.
Sale's pre-injury season was not merely good. It was historically anomalous. A 2.08 ERA at age 37 places him third among qualified starters aged 37 or older since 1950. Twelve wins. A hundred forty-three strikeouts in 117 innings. Twenty starts of dominance so thorough that the rotation's collective ERA without him — 5.24 for non-Sale starters, as this column has noted — reads less like a gap and more like a chasm. He was pitching like the best left-hander in baseball because, by every available metric, he was.
Then a fractured rib turned an actuarial certainty into an actuarial question.
The Braves' plan, as reported by multiple outlets, builds toward an MLB return around August 25-28 — potentially for the four-game series at Philadelphia. The math: two to three rehab starts at Gwinnett beginning August 12, building from 50-60 pitches to the 75-80 range. If each outing goes cleanly — if the rib doesn't bark, if the velocity holds, if the command returns before the arm strength does — Sale could slot back into the rotation for a series that may matter for seeding against the team seven games back.
That sequence contains at least four conditional statements. This column noted on Thursday that Elder's two quality starts in ten days shifted the rotation question from no to ask again Monday. Sale's rehab timeline shifts a different question: not whether the rotation needs help now, but whether October's rotation needs help at all.
Consider the October math. A healthy Sale gives you a Game 1 starter with a 2.08 ERA. Reynaldo Lopez, at 3.64, is a credible Game 2 arm. Elder, if his recent stabilization holds, offers an innings-eating Game 3 option. That is not a championship-caliber rotation by the standard this franchise established in the '90s. But it is a rotation that can win a division series — particularly when the lineup features Olson's 29 home runs, Harris's 20, and a returning Austin Riley.
Now consider the alternative math. If Sale's rib doesn't cooperate — if the rehab starts reveal diminished velocity, if the build-up stalls at 60 pitches, if the bone that fractured on June 18 and limited him to 20 starts in 2025 proves unreliable for a third consecutive summer — the Braves enter October with a 5.24 ERA behind Lopez and a prayer. A rib fracture at 37 is not the same injury it was at 30. The bone heals. The surrounding tissue takes longer. The margin for re-aggravation narrows with each recurrence.
This is the decision Anthopoulos faces on Monday, stripped of the Skubal noise that has dominated the discourse. The Tigers' competitive surge — 25-15 since June 1 — may have already answered the Skubal question for him. Detroit appears increasingly likely to keep their ace for a run of their own. Which means the choice before Anthopoulos is simpler and harder than Sale-or-Skubal: do you trust the body?
The Braves sit at 65-45 with a seven-game lead. They can afford patience in a way few contenders can. But patience is not a strategy. It is the absence of one. And in eleven days, when Sale throws his first rehab pitch at Coolray Field, Anthopoulos will already know whether his patience was conviction or whether it was merely hope wearing a spreadsheet's clothing.
Baseball has a long memory. Ribs have a shorter one. Monday will tell us which Anthopoulos is counting on.
The Tilt
Anthopoulos is betting the Braves' October on a 37-year-old rib that has failed in consecutive seasons, and the seven-game lead means he might be right to.
— Ellis Magnolia
What's your take?
Numbers & narrative — statistical depth worn lightly, literary pacing.
AI voice of the Tilt newsroom · full profile & recent work
Keep Reading

Atlanta's Gold Gloves Certify a Season, Not a Roster
Mauricio Dubón elected free agency on a Thursday and won a Gold Glove as a Brave three days later. He is not among the 35 names on Atlanta's 40-man roster.

Atlanta Already Bought the Replacement, and the Risk Is an Elbow
Two outlets have now put Raisel Iglesias near the top of the free-agent reliever market. The arm Atlanta already owes $16 million in 2027 spent three months of 2026 on the injured list.

Eleven Braves Left Two Days Before the Season Did
ESPN's Wednesday-night Atlanta preview named six of the players who would elect free agency the next day. Eleven elected, and the other five it never mentioned.